Please use this identifier to cite or link to this item: http://ir.juit.ac.in:8080/jspui/jspui/handle/123456789/7745
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrivastava, Sanjeevani Ravi-
dc.contributor.authorRamana, Jayashree [Guided by]-
dc.contributor.authorLahmo, Pemba [Guided by]-
dc.date.accessioned2022-10-13T06:57:53Z-
dc.date.available2022-10-13T06:57:53Z-
dc.date.issued2019-
dc.identifier.urihttp://ir.juit.ac.in:8080/jspui/jspui/handle/123456789/7745-
dc.description.abstract1. SUMMARY I was assigned a market report project on “T-Cell Immunotherapies Market (4th Edition), 2019-2030”. The report features an extensive study of the current market landscape and the future potential of T-cell immunotherapies (focusing particularly on CAR-T therapies, TCR therapies and TIL therapies). One of the key objectives of the study was to review and quantify the future opportunities associated with the ongoing development programs of both small and big pharmaceutical firms. Amongst other elements, the report features basic introduction of Tcell immunotherapy,prevalent and emerging trends related to T-cell immunotherapies as observed on the social media platform, Twitter.In addition, the report includes a detailed assessment of the current market landscape of T-cell immunotherapies with respect to type of therapies, type of developer (industry / non-industry), phase of development, target therapeutic indications, key target antigens, source of T-cells (autologous and allogenic), and route of administration. The reportalso includesanalysis of the partnerships that have been established in the recent past. Further the report includes discussion on price related to different cell-based therapies and the key promotional strategies that are being implemented by the developers of the marketed products.A detailed discussion on innovative technology platforms that are being used for the development of T-cell therapies, along with profiles of key technology providers.An extensive primary and secondary research were carried out to gather relevant information regarding the topic.en_US
dc.language.isoenen_US
dc.publisherJaypee University of Information Technology, Solan, H.P.en_US
dc.subjectT-Cellen_US
dc.subjectImmunotherapiesen_US
dc.titleT-Cell Immunotherapies Market 4th Edition 2019-2030en_US
dc.typeProject Reporten_US
Appears in Collections:B.Tech. Project Reports

Files in This Item:
File Description SizeFormat 
T-Cell Immunotherapies Market 4th Edition 2019-2030.pdf1.34 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.